Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Marimed (MRMD) Gross Margin (2016 - 2025)

Marimed (MRMD) has disclosed Gross Margin for 15 consecutive years, with 25.21% as the latest value for Q4 2025.

  • Quarterly Gross Margin fell 728.0% to 25.21% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 36.28% through Dec 2025, down 350.0% year-over-year, with the annual reading at 36.22% for FY2025, 349.0% down from the prior year.
  • Gross Margin for Q4 2025 was 25.21% at Marimed, down from 40.14% in the prior quarter.
  • The five-year high for Gross Margin was 59.58% in Q2 2021, with the low at 25.21% in Q4 2025.
  • Average Gross Margin over 5 years is 44.58%, with a median of 44.32% recorded in 2022.
  • Peak annual rise in Gross Margin hit 76bps in 2022, while the deepest fall reached -1410bps in 2022.
  • Over 5 years, Gross Margin stood at 49.9% in 2021, then dropped by -12bps to 44.13% in 2022, then increased by 1bps to 44.52% in 2023, then decreased by -27bps to 32.49% in 2024, then fell by -22bps to 25.21% in 2025.
  • According to Business Quant data, Gross Margin over the past three periods came in at 25.21%, 40.14%, and 40.47% for Q4 2025, Q3 2025, and Q2 2025 respectively.